The Israeli Ministry of Health (IL MOH) has approved BeiGene’s TEVIMBRA (tislelizumab) as a monotherapy to treat adults with unresectable or metastatic oesophageal squamous cell carcinoma (OSCC) who ...

Head and neck cancer (HNC) is a devastating disease associated with tobacco smoking. Tobacco smoke-related mRNA phenotypes in HNC were previously documented in vivo and may be differentially expressed ...

Oral cancer often arrives quietly but leaves a devastating mark. Among the many forms it can take, oral squamous cell carcinoma (OSCC) stands out as the most common and one of the most dangerous. Its ...

Oral cancer patients may show different bacteria, viruses, and fungi in their saliva, suggesting an imbalance in the microbiota may aid in the development of oral squamous cell carcinoma (OSCC), ...

Oral squamous cell carcinoma (OSCC) is a leading cause of cancer-related deaths, and early detection is key to improving patient outcomes. However, the mechanisms driving the transition from ...

Researchers have developed a new proof-of-concept test that can accurately identify people with a common oral cancer as well as pre-cancerous tissue. The study is published in the Journal of Oral ...

Candidate marker and omics-based findings associated with tumor progression in disparate patients with oral leukoplakia (a) and tumor (b) in their oral cavities. Oral Leukoplakia (OLK) is recognized ...

Phase I trial of safety of combining BCG with pembrolizumab in patients with high grade superficial bladder cancer unresponsive to previous intravesical therapy. This is an ASCO Meeting Abstract from ...